1715 38TH ST, BOULDER, CO
Market cap: $2.7B (12/18/2025)
Price: $25.55
Appoints Commercial Biotech Executive Christopher Martin to its Board of Directors
Announces Appointment of Michael Nofi as Chief Financial Officer, and the Retirement of Current CFO, R. Michael Carruthers
Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Earnings Release
News
Reports First Quarter 2025 Financial Results and Recent Business Highlights
Investor Presentation
Announces Positive Top-Line Results from Phase 2 CIRRUS-HCM Four-Week Trial of EDG-7500 in Hypertrophic Cardiomyopathy (HCM)
Q3
Q2
Q1
FY 2024
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
S-3ASR
Registration Statement for Additional Securities
Prospectus filed pursuant to Rule 424(b)(3)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report